Aspiriant LLC’s iShares MSCI Emerging Markets ex China ETF EMXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,224
Closed -$210K 310
2023
Q3
$210K Hold
4,224
0.01% 268
2023
Q2
$220K Hold
4,224
0.01% 264
2023
Q1
$208K Hold
4,224
0.01% 265
2022
Q4
$201K Buy
+4,224
New +$201K 0.01% 267

Other funds holding EMXC

Aspiriant LLC's EMXC Position: Q4 2023 in Review

Aspiriant LLC sold out of iShares MSCI Emerging Markets ex China ETF (EMXC) in Q4 2023, closing a stake of 4,224 shares — an estimated $210K sold.

Aspiriant LLC first reported a position in EMXC in Q4 2022 and held it in 4 quarters. The position peaked at $220K in Q2 2023. 655 funds tracked by Wall St. Rank hold EMXC as of Q4 2023.

  • Aspiriant LLC reported no remaining iShares MSCI Emerging Markets ex China ETF position as of Q4 2023 after selling out during the quarter.
  • Aspiriant LLC sold 4,224 iShares MSCI Emerging Markets ex China ETF shares in Q4 2023, an estimated $210K.
  • Aspiriant LLC first reported a position in iShares MSCI Emerging Markets ex China ETF in Q4 2022 and held it in 4 quarters.
  • Aspiriant LLC's iShares MSCI Emerging Markets ex China ETF position peaked at $220K in Q2 2023.
  • 655 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ex China ETF as of Q4 2023.

Based on Aspiriant LLC's 13F filing for Q4 2023, filed 26 Jan 2024.